FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220915015> ?p ?o ?g. }

• W4220915015 endingPage "1327" @default.
• W4220915015 startingPage "1321" @default.
• W4220915015 abstract "Cancer patients with hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are at high risk of viral reactivation after cancer treatment. However, there is a paucity of data regarding HBV or HCV reactivation in cancer patients who receive newer anticancer drugs such as immune checkpoint inhibitors; Bruton tyrosine kinase (BTK) inhibitors; agents targeting CD22, CD38, and CC chemokine receptor 4 (CCR4); and chimeric antigen receptor (CAR) T-cell therapies.In this narrative review article, we describe the rate, characteristics, and outcomes of HBV and HCV reactivation in patients receiving novel systemic anticancer therapies.We searched MEDLINE for all original research articles, case reports, and systematic reviews published in English between July 2013 and December 2021 on cancer patients with HBV or HCV infection receiving novel systemic anticancer therapy.The risk of HBV or HCV reactivation is not well defined in cancer patients receiving immune checkpoint inhibitors (durvalumab, atezolizumab, nivolumab, pembrolizumab, ipilimumab, and tremelimumab); BTK inhibitors (ibrutinib and acalabrutinib); agents targeting CD22 (inotuzumab ozogamicin), CD38 (daratumumab, isatuximab), and CCR4 (mogamulizumab); and CAR T-cell therapy (axicabtagene-ciloleucel). However, screening for chronic HBV and HCV infections and routine monitoring of patients with such infections during novel anticancer therapy are recommended for early identification of viral reactivation, which can impact outcomes of oncologic treatment or be fatal.Specific strategies for risk assessment, monitoring, and management should be designed to reduce the risk of reactivation after novel anticancer therapy in patients with chronic HBV or HCV infections." @default.
• W4220915015 created "2022-04-03" @default.
• W4220915015 creator A5001237986 @default.
• W4220915015 creator A5055182697 @default.
• W4220915015 date "2022-10-01" @default.
• W4220915015 modified "2023-09-24" @default.
• W4220915015 title "Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies" @default.
• W4220915015 cites W1488000644 @default.
• W4220915015 cites W1799522345 @default.
• W4220915015 cites W1994125832 @default.
• W4220915015 cites W2052730188 @default.
• W4220915015 cites W2060070314 @default.
• W4220915015 cites W2088466832 @default.
• W4220915015 cites W2101159020 @default.
• W4220915015 cites W2119962983 @default.
• W4220915015 cites W2132428017 @default.
• W4220915015 cites W2147134417 @default.
• W4220915015 cites W2222056650 @default.
• W4220915015 cites W2335146454 @default.
• W4220915015 cites W2578013986 @default.
• W4220915015 cites W2590941489 @default.
• W4220915015 cites W2605785536 @default.
• W4220915015 cites W2616031529 @default.
• W4220915015 cites W2733007698 @default.
• W4220915015 cites W2751374590 @default.
• W4220915015 cites W2754081264 @default.
• W4220915015 cites W2791839818 @default.
• W4220915015 cites W2792986018 @default.
• W4220915015 cites W2793405459 @default.
• W4220915015 cites W2897435840 @default.
• W4220915015 cites W2903062212 @default.
• W4220915015 cites W2910943640 @default.
• W4220915015 cites W2911738960 @default.
• W4220915015 cites W2914850943 @default.
• W4220915015 cites W2945591768 @default.
• W4220915015 cites W2946307588 @default.
• W4220915015 cites W2959048192 @default.
• W4220915015 cites W2988984460 @default.
• W4220915015 cites W2989703635 @default.
• W4220915015 cites W2990147138 @default.
• W4220915015 cites W2991612669 @default.
• W4220915015 cites W2998314444 @default.
• W4220915015 cites W3004098263 @default.
• W4220915015 cites W3012570191 @default.
• W4220915015 cites W3012874730 @default.
• W4220915015 cites W3015852402 @default.
• W4220915015 cites W3019439019 @default.
• W4220915015 cites W3025324565 @default.
• W4220915015 cites W3043182927 @default.
• W4220915015 cites W3044418753 @default.
• W4220915015 cites W3048897850 @default.
• W4220915015 cites W3081945916 @default.
• W4220915015 cites W3086385843 @default.
• W4220915015 cites W3088449897 @default.
• W4220915015 cites W3095078289 @default.
• W4220915015 cites W3106005610 @default.
• W4220915015 cites W3121674110 @default.
• W4220915015 cites W3128948545 @default.
• W4220915015 cites W3156954304 @default.
• W4220915015 cites W3176511332 @default.
• W4220915015 cites W3184989726 @default.
• W4220915015 cites W3191379976 @default.
• W4220915015 doi "https://doi.org/10.1016/j.cmi.2022.02.042" @default.
• W4220915015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35283317" @default.
• W4220915015 hasPublicationYear "2022" @default.
• W4220915015 type Work @default.
• W4220915015 citedByCount "11" @default.
• W4220915015 countsByYear W42209150152022 @default.
• W4220915015 countsByYear W42209150152023 @default.
• W4220915015 crossrefType "journal-article" @default.
• W4220915015 hasAuthorship W4220915015A5001237986 @default.
• W4220915015 hasAuthorship W4220915015A5055182697 @default.
• W4220915015 hasBestOaLocation W42209150151 @default.
• W4220915015 hasConcept C121608353 @default.
• W4220915015 hasConcept C126322002 @default.
• W4220915015 hasConcept C143998085 @default.
• W4220915015 hasConcept C203014093 @default.
• W4220915015 hasConcept C2522874641 @default.
• W4220915015 hasConcept C2776408679 @default.
• W4220915015 hasConcept C2777382497 @default.
• W4220915015 hasConcept C2777410769 @default.
• W4220915015 hasConcept C2777701055 @default.
• W4220915015 hasConcept C2780030458 @default.
• W4220915015 hasConcept C2780057760 @default.
• W4220915015 hasConcept C2780593183 @default.
• W4220915015 hasConcept C71924100 @default.
• W4220915015 hasConceptScore W4220915015C121608353 @default.
• W4220915015 hasConceptScore W4220915015C126322002 @default.
• W4220915015 hasConceptScore W4220915015C143998085 @default.
• W4220915015 hasConceptScore W4220915015C203014093 @default.
• W4220915015 hasConceptScore W4220915015C2522874641 @default.
• W4220915015 hasConceptScore W4220915015C2776408679 @default.
• W4220915015 hasConceptScore W4220915015C2777382497 @default.
• W4220915015 hasConceptScore W4220915015C2777410769 @default.
• W4220915015 hasConceptScore W4220915015C2777701055 @default.
• W4220915015 hasConceptScore W4220915015C2780030458 @default.
• W4220915015 hasConceptScore W4220915015C2780057760 @default.
• W4220915015 hasConceptScore W4220915015C2780593183 @default.

• next